Title:
Op Gr: Network of Clinical Trials Networks: COVID-19 and Intervention Strategies
Agreement Value:
$6,000,000.00
Agreement Date:
Dec 1, 2020 - Jun 30, 2022
Description:
Applications must ensure relevance to all of the following objectives:
• Establish central coordination and collaboration activities with existing clinical trials groups/networks to increase the availability of high-quality and real-time evidence and build capacity to support Canada’s rapid response to the global pandemic and health emergencies in order to better prevent, detect, treat and/or manage COVID-19;
• Establish a transparent, inclusive, multi-jurisdictional recruitment and membership process that describes benefits for and requirements and expectations of members;
• Collaborate across member networks to establish resource and data sharing policies, increase efficiencies in research and related processes (including, but not limited to ethics review; contracts; common protocols; developing applications for trial funding; consistent and valid patient-oriented outcomes), reduce duplication, and maximize research impact for COVID-19;
• Create data sharing agreements to ensure follow-up of patients through existing administrative data platforms within Canada;
• Adopt a nimble and adaptive strategy for engaging stakeholders in research prioritization and oversight while shifting studies as needed, based on new knowledge and changing COVID-19 landscape;
• Provide evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally; and
• Enhance local, national and/or international clinical trial collaborative efforts by aligning clinical trials networks with other COVID-19 research investments to prevent and/or mitigate the rapid spread of COVID-19 and related negative consequences.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Toronto, Ontario, CA M4N 3M5
Reference Number:
236-2020-2021-Q3-00083
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Additional Information:
Amendment 1: Projected Agreement End Date.
Amendment Date
Jun 30, 2021
Recipient's Legal Name:
Fowler, Robert A
Research Organization:
Sunnybrook Research Institute (Toronto, Ontario)
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.